CCAAT/enhancer binding protein delta (C/EBPδ) deficiency does not affect bleomycin-induced pulmonary fibrosis

MLA

Duitman JanWillem, et al. “CCAAT/Enhancer Binding Protein Delta (C/EBPδ) Deficiency Does Not Affect Bleomycin-Induced Pulmonary Fibrosis.” Journal of Clinical and Translational Research, Jan. 2018. EBSCOhost, https://doi.org/10.18053/jctres.03.2017s2.004.

APA

Duitman JanWillem, Cong Lin, Yves Castier, Keren S. Borensztajn, Sophie Moog, Bruno Crestani, Aurélie Cazes, C. Arnold Spek, & Madeleine Jaillet. (2018). CCAAT/enhancer binding protein delta (C/EBPδ) deficiency does not affect bleomycin-induced pulmonary fibrosis. Journal of Clinical and Translational Research. https://doi.org/10.18053/jctres.03.2017s2.004

Chicago

Duitman JanWillem, Cong Lin, Yves Castier, Keren S. Borensztajn, Sophie Moog, Bruno Crestani, Aurélie Cazes, C. Arnold Spek, and Madeleine Jaillet. 2018. “CCAAT/Enhancer Binding Protein Delta (C/EBPδ) Deficiency Does Not Affect Bleomycin-Induced Pulmonary Fibrosis.” Journal of Clinical and Translational Research, January. doi:10.18053/jctres.03.2017s2.004.